Expand ACIU Menu
ACIU MENU

ACIU Latest Press Releases

-- August 5, 2026 --

AC Immune First Half 2026 Financial and Corporate Update Globe Newswire 7:00 AM

-- July 7, 2026 --

AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC 2026 Globe Newswire 7:00 AM

-- June 30, 2026 --

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer's Disease Globe Newswire 7:00 AM

-- June 11, 2026 --

AC Immune to Receive Research Grant from Goradia Family for Development of ACI-7104 in Parkinson's Disease Globe Newswire 7:00 AM

-- May 22, 2026 --

AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS Globe Newswire 7:00 AM

-- May 12, 2026 --

AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM Globe Newswire 7:00 AM

-- April 30, 2026 --

AC Immune First Quarter 2026 Financial and Corporate Updates Globe Newswire 7:05 AM
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease Globe Newswire 7:00 AM

-- April 7, 2026 --

AC Immune Announces Amendment to Morphomer Tau License and Collaboration Agreement with Lilly Globe Newswire 7:00 AM

-- March 19, 2026 --

AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026 Globe Newswire 7:00 AM

-- March 13, 2026 --

AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes